MAP Pharma (MAPP) Misses Q4 Views by 2c
- Dollar General (DG) Boosts Offer for Family Dollar (FDO) to $80/Share
- Unusual 11 Mid-Day Movers 9/2: (XRSC) (DGLY) (ISNS) Higher; (EXEL) (CONN) (RSH) Lower
- Apple (AAPL) Issues Media Advisory Related to Celebrity Photo Theft
- Thoma Bravo to Acquire Compuware (CPWR) in $2.5B Deal
- Home Depot (HD) Hit on Reports of Massive Credit Card Breach
MAP Pharmaceuticals, Inc. (NASDAQ: MAPP) reported Q4 loss of $0.46, 2 cents worse than the analyst estimate of ($0.44).
You May Also Be Interested In
- Conn's, Inc. (CONN) Misses Q2 EPS Views; Updates FY15 EPS Outlook
- Ocular Therapeutix (OCUL) Tops Q2 EPS by 16c
- Genesco, Inc. (GCO) Misses Q2 EPS Views; Cuts FY15 EPS Outlook
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!